Argent BioPharma Limited

RGT.L · LSE
Analyze with AI
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Assets
Cash & Equivalents£703£240£1,886£5,433
Short-Term Investments£0£0£0£0
Receivables£477£531£1,937£2,349
Inventory£875£1,363£1,838£872
Other Curr. Assets£686£397£796£827
Total Curr. Assets£2,740£2,531£6,458£9,481
Property Plant & Equip (Net)£6,720£7,453£8,798£7,141
Goodwill£0£0£3,146£7,049
Intangibles£0£0£0£0
Long-Term Investments£1,327£0£0£0
Tax Assets£0£0£0£0
Other NC Assets£0£0£156£564
Total NC Assets£8,047£7,453£12,100£14,754
Other Assets£0£0£0£0
Total Assets£10,787£9,984£18,558£24,236
Liabilities
Payables£957£2,186£2,524£1,222
Short-Term Debt£224£191£2,378£4,244
Tax Payable£0£0£0£0
Deferred Revenue£554£658£1,810£0
Other Curr. Liab.£10,442£10,298£996£664
Total Curr. Liab.£12,176£13,332£7,707£6,130
LT Debt£821£385£1,975£1,773
Deferred Rev, NC£3,598£4,278£3,679£2,506
Deferred Tax Liab, NC£0£0£0£0
Other NC Liab.£17£21£16£0
Total NC Liab.£4,436£4,683£5,671£4,280
Other Liabilities£0£0£0£0
Cap. Leases£1,045£575£2,253£1,983
Total Liabilities£16,612£18,015£13,378£10,410
Equity
Pref Stock£0£0£0£0
Common Stock£123,289£103,691£97,251£84,512
Retained Earnings-£129,668-£119,169-£98,345-£77,998
AOCI£648£8,075£6,931£7,320
Other Equity£580£0£0£0
Total Equity-£5,152-£7,403£5,837£13,835
Supplemental Information
Minority Interest-£672-£629-£658-£9
Total Liab. & Tot. Equity£10,787£9,984£18,558£24,236
Net Debt£342£335£2,466£584